Effect of Thickness Variation in Coronal Plug on Root Maturation and Periapical Healing

Overview

d. Second visit: After 3 weeks the patients will be randomly divided into 2 groups: Group A: Patients will be anesthetized 1 carpule of mepivacaine without vasoconstrictor (Mepivacaine HCl 3%), the access will be reopened under rubber dam isolation and the canal will be irrigated with a total of 20 ml of 1.5-2.5% sodium hypochlorite solution. The canal will then be dried with sterile paper points; a sterile sharp needle will be used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process. Over a 15-minute time period, the blood will be allowed to clot to a level of 3 mm below the cemento-enamel junction. A resorbable matrix such as CollaPlug™, Collacote™, CollaTape™ will be placed over the blood clot if necessary. Then 3 mm of MTA will be placed using a suitable size amalgam carrier. A damped cotton pellet on a tweezer placed above the unset MTA and large condenser will be used to seal the canal orifice completely. The access cavity will be sealed with Fuji IX glass ionomer filling material and acid etched composite resin bonded filling material. Group B: The same procedures that will be followed in group A will be also done in group B, except for the thickness of MTA coronal plug which will be 5mm in its thickness e. Follow-up: The patients will be recalled after 1, 6 and 12 months for follow up. The post-treatment follow-up examination will be accomplished as follows: * CBCT scan will be done at 6 and 12 months follow up appointments. * An evaluation was performed on each patient to assess presence of any signs and symptoms clinically by inspection, percussion, palpation, or biting on the treated tooth.

4.1. Trial Design: The trial design of this study is a prospective, 2-arm, 1:1, parallel, randomized, clinical trial (RCT). In RCT, participants are allocated at random to receive one of several interventions according to the research plan created by the investigators. These interventions may be drug, placebo or certain procedure which is not usually known whether it will be helpful, harmful or with no difference than the available alternatives. In RCT the outcomes are measured, so it is considered a quantitative study. This trial design methodology conforms to the Consolidated Standard of Reporting Trials (CONSORT). 4.2. Participants: a. Sample size: Teen participants will be selected from the out patients of the endodontic clinic Faculty of dentistry, Ain Shams University), 9 cases in each group . 4.3. Randomization: Randomization is a process that assigns research participants by chance, rather than by choice, to either the experimental group or the control group. The goal of randomization is to produce comparable groups in terms of general participant characteristics, such as age, gender, chief complain, time pass after trauma, and the other key factors that affect the probable course the disease would take. In this way, the 2 groups are as similar as possible at the start of the study. At the end of the study, if one group has better outcome than the other, the investigators would be able to conclude with some confidence that one intervention is better than the other. Randomization process was achieved in three steps: 1. Sequence generation: Sequence generation will be done for the patient's number (from 1 to 10) using computer sequence generation (www.random.org) which will give a table for group A and group B with randomized patient's numbers (5 number in each group). 2. Allocation concealment mechanism: It is a procedure for protecting the randomization process so that the treatment to be allocated is not known before the patient participated in the study. For the allocation concealment mechanism, each of 10 papers (each paper was eight folded) numbered from 1 to 10 were, individually packed, in opaque envelopes. Each participant picked an envelope at the beginning of the second visit. The number in the envelope determined which procedure will be performed to the patient. The partner will decide the procedure for the operator according to that number. 3. Implementation: The random allocation sequence will be done in the Center of The Evidence Based Dentistry, Faculty of Oral and Dental Medicine, Ain Shams University. However, allocation concealment and participant assignment to the intervention will be done by the other investigator. 4.4. Blinding (Masking): Double blinded (Patient and Assessor). Patient will not informed what procedure he/she was subjected to. Assessor will be blinded to the intervention applied on the patient (during pain and swelling assessment). 4.5. Intervention: Preoperative CBCT scan: A preoperative CBCT scan will be done to all cases with a high resolution Cone Beam Computed Tomography machine (Planmeca ProMax 3d MID; Planmeca, Helsinki, Finland), with endodontic mode, operating at 90 KV, 12mA with a voxel dimension of 75μm. In this study 18 patients will be randomly divided into 2 groups (9 patients per each group), where treatment will be completed in 2 visits. First visit: A calcium hydroxide intracanal medicament will be utilized in all teeth of both groups. Second visit: Group A: Teeth will be treated by regenerative endodontic procedures with placing of 3mm MTA coronal plug . Group B: Teeth will be treated by regenerative endodontic procedures with placing of 5mm MTA coronal plug.